REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 31 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,552,435 | -25.3% | 24,325,000 | -2.0% | 0.08% | -23.4% |
| Q2 2023 | $26,165,550 | -4.4% | 24,825,000 | +11.2% | 0.11% | -13.7% |
| Q1 2023 | $27,381,613 | +14.3% | 22,325,000 | -15.0% | 0.12% | +5.1% |
| Q4 2022 | $23,966,250 | -12.8% | 26,250,000 | +3.7% | 0.12% | -25.3% |
| Q3 2022 | $27,478,000 | +52.2% | 25,325,000 | +13.4% | 0.16% | +64.6% |
| Q2 2022 | $18,056,000 | +28.7% | 22,325,000 | +48.8% | 0.10% | +37.1% |
| Q1 2022 | $14,034,000 | +60.3% | 15,000,000 | +50.0% | 0.07% | +89.2% |
| Q4 2021 | $8,756,000 | +95.5% | 10,000,000 | +156.4% | 0.04% | +85.0% |
| Q3 2021 | $4,479,000 | -1.8% | 3,900,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $4,563,000 | – | 3,900,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |